Care Setting

Personalised evidence-based medicine to minimise polypharmacy

4 March 2025A consultant pharmacist used case studies to illustrate a patient-centered approach to deprescribing in patients with problematic polypharmacy.

'Flozin' suggestions for adults with swallowing difficulties

27 February 2025A range of SGLT2 inhibitor ('flozin') formulations are suitable for use in adults with swallowing difficulties

'Gliptin' suggestions for adults with swallowing difficulties

27 February 2025A range of DPP-4 inhibitor ('gliptin') formulations are suitable for use in adults with swallowing difficulties

Personalising evidence-based medicine to reduce polypharmacy

11 February 2025An insight on principles of patient centred structured medication reviews; using the current evidence and shared decision making to facilitate de-prescribing.

Worked example of assessing the risk of transcribing

28 January 2025Example where medicines are prescribed by both the patient’s GP and specialist clinicians, and are administered in a patient’s home.

Offender healthcare settings and transcribing

28 January 2025Consideration needs to be given to the risk factors particularly associated with transcribing in offender healthcare settings

Transcribing in the patient's home with healthcare input

28 January 2025Consideration needs to be given to the risk factors particularly associated with transcribing in the patient's home with healthcare input

Non-acute settings with healthcare input and transcribing

28 January 2025Consideration needs to be given to the risk factors particularly associated with transcribing in non-acute settings with healthcare input

Semi-acute settings and transcribing

28 January 2025Consideration needs to be given to the risk factors particularly associated with transcribing in semi-acute settings

Acute settings and transcribing

28 January 2025Consideration needs to be given to the risk factors particularly associated with transcribing in acute settings

SPS - Specialist Pharmacy Service

NHS